Advanced Bionics launches Clarion 1.2 cochlear implant in U.S. following FDA approval Aug. 2.
This article was originally published in The Gray Sheet
ADVANCED BIONICS CLARION 1.2 COCHLEAR IMPLANT SHIPMENTS BEGIN following FDA approval Aug. 2 of a premarket approval application supplement for the device. A larger version of the device, the Clarion 1.0, was approved on March 29 ("The Gray Sheet" April 15, p. 10), however, the company delayed a full-scale launch until receiving a green light from the agency to commercialize the 1.2 model. The firm is no longer manufacturing the first generation device.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.